Project Grant R21EY034330
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$412K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will provide $243,000 to the University of Cincinnati over a 2-year period from February 1, 2025 to January 31, 2027. The research aims to elucidate the critical role of the SMAD4 protein as a master regulator controlling the balance between extracellular matrix (ECM) synthesis and degradation in the corneal stroma, which is essential for corneal morphogenesis and...
The federal Project Grant award R01EY035319 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to investigate the role of light and photoreceptor proteins (opsins) in corneal wound healing. The central hypothesis is that light modulates corneal wound healing via an opsin-dependent mechanism. The University of Washington, the award recipient, will conduct in vivo and ex vivo experiments in mouse models to (1) test the light regimen necessary...
This federal Project Grant award of $431,750.00 from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to develop a novel, femtosecond (FS) laser-based approach for delivering gene therapy to the cornea. The key objectives are to create microchannels through the corneal epithelium to enhance transepithelial drug diffusion, and use subthreshold FS laser pulses to open temporary pores in stromal cells for plasmid-based gene delivery,...
The National Eye Institute (NEI) awarded a $433,125 federal Project Grant (CFDA 93.867 - Vision Research) to The Ohio State University to leverage data from the Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) study to address critical clinical questions in myopia control. The funded research aims to analyze axial length data to determine whom to treat and whether myopia control treatments are beneficial, assess the effects of time spent outdoors and sports...
The National Eye Institute (NEI) awarded a $237,996 Project Grant (CFDA 93.867 - Vision Research) to The Regents of the University of Colorado (University of Colorado) to investigate new methods for high-resolution, wide-field, 3D imaging of the cornea. The project aims to develop an imaging approach using speckle illumination holography that can capture detailed corneal structures, including cellular and nerve morphology, in living human eyes. This new technique is intended to overcome...
The National Eye Institute (NEI) awarded a $332,179 Project Grant (CFDA 93.867 Vision Research) to Diopter Technologies, Inc. to develop sustained-release contact lenses that can deliver the drug cysteamine to treat the ocular complications of cystinosis, a rare metabolic disease. The goal is to create a daily disposable contact lens that can replace the current 8 times per day cysteamine eye drop regimen, which is difficult for patients and can cause side effects. The proposed research...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) to The University of Iowa to investigate the role of ferroptosis, a form of cell death, in the development and progression of Fuchs Endothelial Corneal Dystrophy (FECD). The $588,731 award, active from March 1, 2025 to February 28, 2030, aims to clarify how genetic and environmental risk factors, such as extracellular matrix changes and ultraviolet light exposure, contribute to FECD through ferroptosis....
The National Eye Institute (NEI) has awarded a 5-year, $2,174,069 Project Grant (CFDA 93.867 - Vision Research) to The Trustees of the University of Pennsylvania to advance research on Fuchs' Endothelial Corneal Dystrophy (FECD). The key objectives are to elucidate the regenerative potential of corneal endothelial cells and develop innovative mRNA-based treatments to restore corneal transparency and visual function in FECD patients. The project involves a two-pronged approach. Aim 1 will use...
This $176,550 Project Grant award from the National Eye Institute (NEI)'s Vision Research program (CFDA 93.867) will support research to optimize C-Met signaling to enhance corneal epithelial homeostasis. The goal is to determine if inhibiting the negative regulation of the C-Met receptor can prolong its signaling activity and accelerate corneal wound healing. The research will be conducted by the University of Louisville and will involve in vitro studies to block C-Met ubiquitylation and in...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will provide $623,090 to Oregon Health & Science University (OHSU) from September 1, 2024 to June 30, 2029. The project aims to develop a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device optimized for the rat eye. This will enable in vivo quantification of total retinal blood flow, oxygen saturation, and vascular changes in the oxygen-induced...